Comparison between two antibiotics ciprofloxacin and co-trimoxazole in ?preventing infections as prophylaxis during treatment in multiple myeloma ?patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141209020258N75

Enrollment

Registered

2018-04-30

Start date

2016-07-22

Completion date

Unknown

Last updated

2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple myeloma ?. Multiple myeloma

Interventions

Intervention 1: Intervention group: We prescribed Ciprofloxacin 500 milligram daily for group A. Intervention 2: Intervention group: We prescribed Co-trimoxazole 400/1600 daily for group B.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with multiple myeloma

Exclusion criteria

Exclusion criteria: Dissatisfaction to cooperate

Design outcomes

Primary

Measure	Time frame
Infection status. Timepoint: End of study. Method of measurement: Clinical observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Aloarash Anoshirvani

Arak University of Medical Sciences

anoshirani@arakmu.ac.ir+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026